Singapore Institute of Advanced Medicine Trims Loss in Fiscal H1

MT Newswires
2025/02/18

Singapore Institute of Advanced Medicine (SGX:9G2) trimmed its loss after tax for the fiscal first half ended Dec. 31, 2024 to SG$12.6 million from SG$21.2 million a year earlier, according to a Monday filing with the Singapore Exchange.

Loss per share from continuing operations decreased to SG$0.0135 from SG$0.0311 in the comparable period.

Revenue, however, declined 6% year over year to SG$8.0 million from SG$8.5 million.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10